Satellite Banner
Technology Networks Header
Saturday, May 25, 2013
Technology Networks
 
Register | Sign in
Home Page
  News

Empire Genomics Licenses First Known DNA Biomarker for Multiple Myeloma

Published: Thursday, November 29, 2012
Last Updated: Thursday, November 29, 2012
Bookmark and Share
Detection of gene abnormalities may help patients and physicians determine the best approach to treatment, improve survival rate and lower treatment costs.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.


Scientific News
NIH Researchers Conduct First Genomic Survey of Human Skin Fungal Diversity
Location on the body surface determines fungal composition with the greatest diversity on feet.
App Helps Doctors, Students Learn to Diagnose Neurological Symptoms and Disease
The new app that presents a novel approach to learning the neurological physical exam, a challenging series of assessments aimed at diagnosing neurological disorders in patients.
Flu in Pregnancy May Quadruple Child’s Risk for Bipolar Disorder
NIH-funded study adds to evidence of overlap with Schizophrenia.
A Cautionary Tale on Genome-Sequencing Diagnostics for Rare Diseases
Studies in several children have raising new questions about inheritance, genomic sequencing, and diagnostic.
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Rapid development of MS-based proteomic techniques in the last decade that has immensely helped researchers in candidate biomarker discovery.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Genetic Test Helps Predict Risk of Prostate Cancer Recurrence
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
New Lung Cancer Guidelines Recommends Offering Screening to High-Risk Individuals
Advances in treatment have major impact on short- and long-term outcomes.
Genomic Analysis of Endometrial Tumors
Genomic classification of endometrial tumors could help guide treatment strategies, according to a new analysis.
Diagnostic Errors More Common, Costly and Harmful Than Treatment Mistakes
In reviewing 25 years of U.S. malpractice claim payouts, researchers found that diagnostic errors accounted for the largest fraction of claims, the most severe patient harm, and the highest total of penalty payouts.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net